04/09/2024 Limited availability of medicinal product based on peginterferon alfa-2a, solution for injection: recommendations for physicians (-specialists) and (hospital) pharmacists.
20/08/2024 Call to professionals responsible for materiovigilance: take part in European Commission survey on electronic instructions for use
06/08/2024 Warning: serious adverse reactions when administering the veterinary medicinal product Senvelgo (velagliflozin molecule) to cats suffering from diabetes
26/07/2024 PRAC July 2024 – New recommendations for GLP-1 receptor agonists and direct healthcare professional communication for glatiramer acetate containing products